| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transcription coregulator activity | 1.47e-04 | 562 | 70 | 9 | GO:0003712 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 1.51e-04 | 229 | 70 | 6 | GO:0003714 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | ZZZ3 UBE3A SMARCC2 NCOA4 SSX3 SSX5 USP15 TFAP2A ZNF541 HNRNPU HR FBXW7 | 6.49e-04 | 1160 | 70 | 12 | GO:0030674 |
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | 6.91e-04 | 114 | 70 | 4 | GO:0004843 | |
| GeneOntologyMolecularFunction | vinculin binding | 9.22e-04 | 13 | 70 | 2 | GO:0017166 | |
| GeneOntologyMolecularFunction | deubiquitinase activity | 9.47e-04 | 124 | 70 | 4 | GO:0101005 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | 1.37e-03 | 137 | 70 | 4 | GO:0019783 | |
| Domain | SSX | 1.09e-06 | 6 | 72 | 3 | IPR028804 | |
| Domain | SSXRD | 3.03e-06 | 8 | 72 | 3 | PF09514 | |
| Domain | SSXRD_motif | 3.03e-06 | 8 | 72 | 3 | IPR019041 | |
| Domain | KRAB_RELATED | 8.87e-06 | 11 | 72 | 3 | PS50806 | |
| Domain | - | 1.47e-05 | 2 | 72 | 2 | 1.20.1420.10 | |
| Domain | Talin_middle | 1.47e-05 | 2 | 72 | 2 | PF09141 | |
| Domain | VBS | 1.47e-05 | 2 | 72 | 2 | PF08913 | |
| Domain | Vinculin-bd_dom | 1.47e-05 | 2 | 72 | 2 | IPR015009 | |
| Domain | Talin_cent | 1.47e-05 | 2 | 72 | 2 | IPR015224 | |
| Domain | Krueppel-associated_box-rel | 1.53e-05 | 13 | 72 | 3 | IPR003655 | |
| Domain | Talin-1 | 4.39e-05 | 3 | 72 | 2 | IPR015710 | |
| Domain | I_LWEQ | 8.75e-05 | 4 | 72 | 2 | PF01608 | |
| Domain | ILWEQ_dom | 8.75e-05 | 4 | 72 | 2 | IPR002558 | |
| Domain | I_LWEQ | 8.75e-05 | 4 | 72 | 2 | PS50945 | |
| Domain | ILWEQ | 8.75e-05 | 4 | 72 | 2 | SM00307 | |
| Domain | FERM_f0 | 8.75e-05 | 4 | 72 | 2 | IPR032425 | |
| Domain | FERM_f0 | 8.75e-05 | 4 | 72 | 2 | PF16511 | |
| Domain | ILWEQ | 8.75e-05 | 4 | 72 | 2 | PD011820 | |
| Domain | - | 8.75e-05 | 4 | 72 | 2 | 1.20.1410.10 | |
| Domain | Vinculin/catenin | 3.04e-04 | 7 | 72 | 2 | IPR006077 | |
| Domain | Myb_DNA-binding | 3.29e-04 | 35 | 72 | 3 | PF00249 | |
| Domain | Fol_N | 7.88e-04 | 11 | 72 | 2 | IPR003645 | |
| Domain | FOLN | 7.88e-04 | 11 | 72 | 2 | SM00274 | |
| Domain | SANT | 9.45e-04 | 50 | 72 | 3 | SM00717 | |
| Domain | SANT/Myb | 1.06e-03 | 52 | 72 | 3 | IPR001005 | |
| Domain | IRS_PTB | 1.29e-03 | 14 | 72 | 2 | IPR002404 | |
| Domain | TF_A-like/BEX | 1.29e-03 | 14 | 72 | 2 | IPR021156 | |
| Domain | BEX | 1.29e-03 | 14 | 72 | 2 | PF04538 | |
| Domain | IRS | 1.29e-03 | 14 | 72 | 2 | PF02174 | |
| Domain | USP_CS | 2.11e-03 | 66 | 72 | 3 | IPR018200 | |
| Domain | ZZ | 2.15e-03 | 18 | 72 | 2 | PF00569 | |
| Domain | ZF_ZZ_2 | 2.15e-03 | 18 | 72 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 2.15e-03 | 18 | 72 | 2 | PS01357 | |
| Domain | Znf_ZZ | 2.40e-03 | 19 | 72 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 2.40e-03 | 19 | 72 | 2 | SM00291 | |
| Domain | USP_1 | 2.50e-03 | 70 | 72 | 3 | PS00972 | |
| Domain | UCH | 2.60e-03 | 71 | 72 | 3 | PF00443 | |
| Domain | USP_2 | 2.60e-03 | 71 | 72 | 3 | PS00973 | |
| Domain | USP_3 | 2.71e-03 | 72 | 72 | 3 | PS50235 | |
| Domain | USP_dom | 2.71e-03 | 72 | 72 | 3 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 2.71e-03 | 72 | 72 | 3 | IPR001394 | |
| Domain | FERM_CS | 3.83e-03 | 24 | 72 | 2 | IPR019747 | |
| Domain | SANT_dom | 4.49e-03 | 26 | 72 | 2 | IPR017884 | |
| Domain | SANT | 5.19e-03 | 28 | 72 | 2 | PS51293 | |
| Domain | Ubiquitin-rel_dom | 5.57e-03 | 184 | 72 | 4 | IPR029071 | |
| Pubmed | BPTF EPRS1 UBE3A TLN1 DEF6 UBA2 DIDO1 UTRN HSPA4 EMSY GOLGA4 HNRNPU | 1.32e-11 | 360 | 73 | 12 | 33111431 | |
| Pubmed | BPTF EPRS1 ZZZ3 CDK12 DCTN2 TLN1 DIDO1 PEAK1 USP15 TFAP2A EMSY SPDL1 | 1.63e-09 | 549 | 73 | 12 | 38280479 | |
| Pubmed | TET2 BPTF EPRS1 ATXN2 TLN1 UBA2 SMARCC2 DIDO1 HMGN2 TFAP2A HSPA4 HNRNPAB EMSY HNRNPU ZNF292 | 7.82e-09 | 1103 | 73 | 15 | 34189442 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | BPTF EPRS1 ZZZ3 ATXN2 CDK12 SMARCC2 DIDO1 HMGN2 API5 SSX2 TFAP2A HNRNPAB EMSY HNRNPU | 1.02e-08 | 954 | 73 | 14 | 36373674 |
| Pubmed | 2.54e-08 | 225 | 73 | 8 | 12168954 | ||
| Pubmed | Heterogeneous expression of the SSX cancer/testis antigens in human melanoma lesions and cell lines. | 3.54e-08 | 4 | 73 | 3 | 10749136 | |
| Pubmed | TET2 EPRS1 ZBTB44 ZNF133 ACTR8 ZNF532 UBE3A TLN2 BEX4 SPARCL1 UTRN USP47 ZNF292 WDR47 | 3.97e-07 | 1285 | 73 | 14 | 35914814 | |
| Pubmed | 4.93e-07 | 8 | 73 | 3 | 12007189 | ||
| Pubmed | 4.93e-07 | 8 | 73 | 3 | 22017400 | ||
| Pubmed | 1.16e-06 | 506 | 73 | 9 | 30890647 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | EPRS1 DCTN2 TLN1 UBA2 SMARCC2 TLN2 HMGN2 API5 UTRN HSPA4 HNRNPU | 1.51e-06 | 847 | 73 | 11 | 35235311 |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | PRUNE2 EPRS1 UBE3A DCTN2 TLN1 UBA2 THUMPD1 API5 USP15 HSPA4 HNRNPAB USP47 HNRNPU SPDL1 | 1.73e-06 | 1455 | 73 | 14 | 22863883 |
| Pubmed | EPRS1 UBE3A CDK12 DCTN2 TLN1 UBA2 USP15 HSPA4 USP47 HNRNPU ZNF292 | 2.13e-06 | 878 | 73 | 11 | 37223481 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PRUNE2 BPTF ZNF133 USF3 ZNF532 ATXN2 KIAA0232 SYTL1 ATAT1 SSX2 USP15 UTRN GOLGA4 HNRNPU | 2.26e-06 | 1489 | 73 | 14 | 28611215 |
| Pubmed | 2.33e-06 | 551 | 73 | 9 | 34728620 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | EPRS1 ZBTB44 URB1 ZZZ3 AFAP1L2 LOXHD1 TLN1 TCEAL2 UTRN HNRNPU | 3.17e-06 | 736 | 73 | 10 | 29676528 |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 16546222 | ||
| Pubmed | The PMA-induced specific association of LFA-1 and talin in intact cloned T helper cells. | 4.35e-06 | 2 | 73 | 2 | 2150484 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 26822056 | ||
| Pubmed | Extracellular rigidity sensing by talin isoform-specific mechanical linkages. | 4.35e-06 | 2 | 73 | 2 | 26523364 | |
| Pubmed | 4.35e-06 | 2 | 73 | 2 | 22306379 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 4.94e-06 | 774 | 73 | 10 | 15302935 | |
| Pubmed | 6.57e-06 | 124 | 73 | 5 | 20850016 | ||
| Pubmed | 6.74e-06 | 472 | 73 | 8 | 38943005 | ||
| Pubmed | EPRS1 CTTNBP2 DCTN2 TLN1 CPEB4 SMARCC2 TLN2 PEAK1 UTRN HSPA4 HNRNPAB HNRNPU WDR47 | 7.93e-06 | 1431 | 73 | 13 | 37142655 | |
| Pubmed | BPTF ZNF532 UBE3A CDK12 UBA2 THUMPD1 SMARCC2 DIDO1 HMGN2 API5 TFAP2A | 8.37e-06 | 1014 | 73 | 11 | 32416067 | |
| Pubmed | 1.15e-05 | 21 | 73 | 3 | 12216073 | ||
| Pubmed | Type I gamma phosphatidylinositol phosphate kinase targets and regulates focal adhesions. | 1.30e-05 | 3 | 73 | 2 | 12422220 | |
| Pubmed | Activated β2 Integrins Restrict Neutrophil Recruitment during Murine Acute Pseudomonal Pneumonia. | 1.30e-05 | 3 | 73 | 2 | 28157452 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 26337492 | ||
| Pubmed | Mechanotransduction in talin through the interaction of the R8 domain with DLC1. | 1.30e-05 | 3 | 73 | 2 | 30028837 | |
| Pubmed | Blocking neutrophil integrin activation prevents ischemia-reperfusion injury. | 1.30e-05 | 3 | 73 | 2 | 26169939 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 19952892 | ||
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 19160486 | ||
| Pubmed | Talin and vinculin are downregulated in atherosclerotic plaque; Tampere Vascular Study. | 1.30e-05 | 3 | 73 | 2 | 27816808 | |
| Pubmed | SSX2-4 expression in early-stage non-small cell lung cancer. | 1.30e-05 | 3 | 73 | 2 | 24645645 | |
| Pubmed | Cytoskeletal proteins talin and vinculin in integrin-mediated adhesion. | 1.30e-05 | 3 | 73 | 2 | 15494027 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 18792400 | ||
| Pubmed | Vinculin controls talin engagement with the actomyosin machinery. | 1.30e-05 | 3 | 73 | 2 | 26634421 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 22665520 | ||
| Pubmed | An essential role for talin during alpha(M)beta(2)-mediated phagocytosis. | 1.30e-05 | 3 | 73 | 2 | 17202407 | |
| Pubmed | 1.30e-05 | 3 | 73 | 2 | 28698364 | ||
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | BPTF EPRS1 ZBTB44 URB1 ACTR8 ZZZ3 DIDO1 HMGN2 TFAP2A HNRNPAB EMSY HNRNPU | 1.51e-05 | 1294 | 73 | 12 | 30804502 |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | BPTF NRDE2 ZNF532 CDK12 CPEB4 USP12 SMARCC2 DIDO1 HNRNPAB HNRNPU ZNF292 | 1.53e-05 | 1082 | 73 | 11 | 38697112 |
| Pubmed | 1.55e-05 | 148 | 73 | 5 | 22898364 | ||
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | 1.60e-05 | 701 | 73 | 9 | 30196744 | |
| Pubmed | 1.73e-05 | 538 | 73 | 8 | 28524877 | ||
| Pubmed | 1.94e-05 | 155 | 73 | 5 | 33838681 | ||
| Pubmed | EPRS1 UBE3A CPEB4 SMARCC2 TLN2 SPARCL1 PEAK1 USP15 HNRNPAB HNRNPU WDR47 | 2.46e-05 | 1139 | 73 | 11 | 36417873 | |
| Pubmed | 2.48e-05 | 274 | 73 | 6 | 34244482 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 2.50e-05 | 934 | 73 | 10 | 33916271 | |
| Pubmed | NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. | 2.50e-05 | 27 | 73 | 3 | 23395962 | |
| Pubmed | c-Abl kinase is required for beta 2 integrin-mediated neutrophil adhesion. | 2.60e-05 | 4 | 73 | 2 | 19234221 | |
| Pubmed | Cathepsin X cleavage of the beta2 integrin regulates talin-binding and LFA-1 affinity in T cells. | 2.60e-05 | 4 | 73 | 2 | 21454358 | |
| Pubmed | The stomatin-like protein SLP-1 and Cdk2 interact with the F-Box protein Fbw7-γ. | 2.60e-05 | 4 | 73 | 2 | 23082202 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 30242097 | ||
| Pubmed | Distinct roles for talin-1 and kindlin-3 in LFA-1 extension and affinity regulation. | 2.60e-05 | 4 | 73 | 2 | 22431571 | |
| Pubmed | Rap1 controls activation of the α(M)β(2) integrin in a talin-dependent manner. | 2.60e-05 | 4 | 73 | 2 | 20665668 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 21134644 | ||
| Pubmed | E6-AP association promotes SOD1 aggresomes degradation and suppresses toxicity. | 2.60e-05 | 4 | 73 | 2 | 23040663 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 19233847 | ||
| Pubmed | Vinculin regulates assembly of talin: β3 integrin complexes. | 2.60e-05 | 4 | 73 | 2 | 24446374 | |
| Pubmed | Endothelial cell talin1 is essential for embryonic angiogenesis. | 2.60e-05 | 4 | 73 | 2 | 21081121 | |
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 15581353 | ||
| Pubmed | 2.60e-05 | 4 | 73 | 2 | 26483383 | ||
| Pubmed | An Oct4-centered protein interaction network in embryonic stem cells. | 2.77e-05 | 167 | 73 | 5 | 20362541 | |
| Pubmed | 2.90e-05 | 83 | 73 | 4 | 28794006 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 3.03e-05 | 582 | 73 | 8 | 20467437 | |
| Pubmed | CTTNBP2 ATXN2 UBE3A SMARCC2 DIDO1 TLN2 EMSY GOLGA4 HNRNPU WDR47 | 3.24e-05 | 963 | 73 | 10 | 28671696 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 19805288 | ||
| Pubmed | Talin1 regulates integrin turnover to promote embryonic epithelial morphogenesis. | 4.33e-05 | 5 | 73 | 2 | 21670148 | |
| Pubmed | Quantification of integrin receptor agonism by fluorescence lifetime imaging. | 4.33e-05 | 5 | 73 | 2 | 18216331 | |
| Pubmed | Ubiquitin ligase CHIP regulates OTUD3 stability and suppresses tumour metastasis in lung cancer. | 4.33e-05 | 5 | 73 | 2 | 32483383 | |
| Pubmed | SSX: a multigene family with several members transcribed in normal testis and human cancer. | 4.33e-05 | 5 | 73 | 2 | 9378559 | |
| Pubmed | The cytosolic protein talin induces an intermediate affinity integrin alphaLbeta2. | 4.33e-05 | 5 | 73 | 2 | 17591777 | |
| Pubmed | 4.33e-05 | 5 | 73 | 2 | 26821125 | ||
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | 4.81e-05 | 807 | 73 | 9 | 22681889 | |
| Pubmed | 5.53e-05 | 35 | 73 | 3 | 24515614 | ||
| Pubmed | 6.48e-05 | 6 | 73 | 2 | 35742816 | ||
| Pubmed | Mice carrying a complete deletion of the talin2 coding sequence are viable and fertile. | 6.48e-05 | 6 | 73 | 2 | 22925892 | |
| Pubmed | Rapid leukocyte migration by integrin-independent flowing and squeezing. | 6.48e-05 | 6 | 73 | 2 | 18451854 | |
| Pubmed | Macrophage network dynamics depend on haptokinesis for optimal local surveillance. | 6.48e-05 | 6 | 73 | 2 | 35343899 | |
| Pubmed | 6.80e-05 | 653 | 73 | 8 | 22586326 | ||
| Pubmed | KCTD9 inhibits the Wnt/β-catenin pathway by decreasing the level of β-catenin in colorectal cancer. | 7.01e-05 | 104 | 73 | 4 | 36055981 | |
| Pubmed | A genome-wide RNAi screen identifies multiple synthetic lethal interactions with the Ras oncogene. | 7.07e-05 | 331 | 73 | 6 | 19490893 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 7.19e-05 | 332 | 73 | 6 | 32786267 | |
| Pubmed | 7.56e-05 | 335 | 73 | 6 | 15741177 | ||
| Pubmed | 8.11e-05 | 494 | 73 | 7 | 26831064 | ||
| Pubmed | A High-Density Map for Navigating the Human Polycomb Complexome. | 8.22e-05 | 495 | 73 | 7 | 27705803 | |
| Pubmed | Talin regulates integrin β1-dependent and -independent cell functions in ureteric bud development. | 9.06e-05 | 7 | 73 | 2 | 28993400 | |
| Pubmed | Dido3-dependent SFPQ recruitment maintains efficiency in mammalian alternative splicing. | 9.06e-05 | 7 | 73 | 2 | 30931476 | |
| Pubmed | 9.06e-05 | 7 | 73 | 2 | 23266827 | ||
| Pubmed | 9.08e-05 | 503 | 73 | 7 | 16964243 | ||
| Pubmed | FAF1 phosphorylation by AKT accumulates TGF-β type II receptor and drives breast cancer metastasis. | 1.11e-04 | 224 | 73 | 5 | 28443643 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EPRS1 URB1 UBE3A TLN1 SMARCC2 UTRN HSPA4 HNRNPAB GOLGA4 HNRNPU WDR47 | 1.15e-04 | 1353 | 73 | 11 | 29467282 |
| Pubmed | C16orf72/HAPSTR1 is a molecular rheostat in an integrated network of stress response pathways. | 1.18e-04 | 119 | 73 | 4 | 35776542 | |
| Pubmed | 1.21e-04 | 8 | 73 | 2 | 11381084 | ||
| Pubmed | Arginylation-dependent neural crest cell migration is essential for mouse development. | 1.21e-04 | 8 | 73 | 2 | 20300656 | |
| Pubmed | CHIP and BAP1 Act in Concert to Regulate INO80 Ubiquitination and Stability for DNA Replication. | 1.21e-04 | 8 | 73 | 2 | 33658435 | |
| Pubmed | 1.55e-04 | 9 | 73 | 2 | 22976293 | ||
| Interaction | H2BC21 interactions | BPTF EPRS1 USF3 ZZZ3 DCTN2 TLN1 USP12 SMARCC2 CRYBG1 DIDO1 HMGN2 AKAP11 USP15 TFAP2A HNRNPU ZNF292 FBXW7 | 3.39e-10 | 696 | 73 | 17 | int:H2BC21 |
| Interaction | ACTB interactions | TET2 ACE2 EPRS1 ACTR8 CTTNBP2 ZZZ3 ATXN2 UBE3A DCTN2 CPEB4 SMARCC2 API5 PEAK1 USP15 HSPA4 HNRNPAB HNRNPU SPDL1 | 4.01e-08 | 1083 | 73 | 18 | int:ACTB |
| Interaction | MYH10 interactions | TET2 ACE2 DCTN2 SMARCC2 USP15 HSPA4 GOLGA4 USP47 HNRNPU SPDL1 FBXW7 | 6.53e-08 | 359 | 73 | 11 | int:MYH10 |
| Interaction | CEBPA interactions | TET2 BPTF EPRS1 URB1 ATXN2 UBE3A TLN1 UBA2 SMARCC2 DIDO1 HMGN2 TFAP2A HSPA4 HNRNPAB EMSY HNRNPU ZNF292 | 1.62e-06 | 1245 | 73 | 17 | int:CEBPA |
| Interaction | HDAC1 interactions | TET2 BPTF ACTR8 ZZZ3 TLN1 SMARCC2 SSX2 USP15 UTRN HSPA4 EMSY GOLGA4 USP47 HNRNPU SPDL1 HR | 1.70e-06 | 1108 | 73 | 16 | int:HDAC1 |
| Interaction | SMC5 interactions | BPTF EPRS1 ZZZ3 ATXN2 CDK12 UBA2 SMARCC2 DIDO1 HMGN2 API5 SSX2 TFAP2A HNRNPAB EMSY HNRNPU | 2.38e-06 | 1000 | 73 | 15 | int:SMC5 |
| Interaction | WWTR1 interactions | 2.79e-06 | 422 | 73 | 10 | int:WWTR1 | |
| Interaction | FMR1 interactions | EPRS1 ATXN2 CPEB4 SMARCC2 BEX4 HNRNPAB EMSY GOLGA4 HNRNPU FBXW7 WDR47 | 3.41e-06 | 536 | 73 | 11 | int:FMR1 |
| Interaction | MAP10 interactions | 3.51e-06 | 29 | 73 | 4 | int:MAP10 | |
| Interaction | H3-4 interactions | 4.74e-06 | 448 | 73 | 10 | int:H3-4 | |
| Interaction | PABPN1 interactions | 6.12e-06 | 192 | 73 | 7 | int:PABPN1 | |
| Interaction | YAP1 interactions | BPTF EPRS1 ZZZ3 CDK12 DCTN2 TLN1 UBA2 THUMPD1 SMARCC2 DIDO1 USP15 HSPA4 USP47 HNRNPU FBXW7 | 7.19e-06 | 1095 | 73 | 15 | int:YAP1 |
| Interaction | HSP90AB1 interactions | STK32A TET2 ACE2 UBE3A DCTN2 TLN1 SMARCC2 HMGN2 PEAK1 USP15 HSPA4 ZNF541 HNRNPU SPDL1 | 7.53e-06 | 960 | 73 | 14 | int:HSP90AB1 |
| Interaction | RO60 interactions | 7.99e-06 | 200 | 73 | 7 | int:RO60 | |
| Interaction | RPL13A interactions | ACE2 EPRS1 URB1 ATXN2 CDK12 API5 USP15 HNRNPAB ZNF541 HNRNPU FBXW7 | 8.61e-06 | 591 | 73 | 11 | int:RPL13A |
| Interaction | DEK interactions | 1.06e-05 | 209 | 73 | 7 | int:DEK | |
| Interaction | SRA1 interactions | 1.26e-05 | 83 | 73 | 5 | int:SRA1 | |
| Interaction | YBX1 interactions | ACE2 EPRS1 ATXN2 THUMPD1 OTUD3 API5 TFAP2A HNRNPAB USP47 HNRNPU SPDL1 FBXW7 | 1.52e-05 | 752 | 73 | 12 | int:YBX1 |
| Interaction | MYH9 interactions | TET2 ACE2 UBE3A TLN1 OTUD3 USP15 ITGB2 GOLGA4 USP47 HNRNPU SPDL1 FBXW7 | 1.56e-05 | 754 | 73 | 12 | int:MYH9 |
| Interaction | ERG interactions | 1.62e-05 | 223 | 73 | 7 | int:ERG | |
| Interaction | HNRNPD interactions | ACE2 EPRS1 ATXN2 TLN1 SMARCC2 TLN2 HSPA4 HNRNPAB GOLGA4 HNRNPU FBXW7 | 1.76e-05 | 638 | 73 | 11 | int:HNRNPD |
| Interaction | MDC1 interactions | 1.81e-05 | 414 | 73 | 9 | int:MDC1 | |
| Interaction | TCEAL4 interactions | 2.30e-05 | 46 | 73 | 4 | int:TCEAL4 | |
| Interaction | RPS4X interactions | 2.40e-05 | 540 | 73 | 10 | int:RPS4X | |
| Interaction | DHX9 interactions | ACE2 EPRS1 ATXN2 DIDO1 OTUD3 API5 UTRN HNRNPAB HNRNPU SPDL1 FBXW7 | 2.47e-05 | 662 | 73 | 11 | int:DHX9 |
| Interaction | PRMT1 interactions | TET2 ACE2 EPRS1 ATXN2 UBE3A DCTN2 API5 USP15 HSPA4 HNRNPAB GOLGA4 HNRNPU FBXW7 | 2.58e-05 | 929 | 73 | 13 | int:PRMT1 |
| Interaction | TERF2IP interactions | 2.89e-05 | 552 | 73 | 10 | int:TERF2IP | |
| Interaction | TFCP2L1 interactions | 2.98e-05 | 99 | 73 | 5 | int:TFCP2L1 | |
| Interaction | GAPDH interactions | TET2 ACE2 EPRS1 ATXN2 TLN1 TLN2 HSPA4 HNRNPAB GOLGA4 HNRNPU SPDL1 | 3.42e-05 | 686 | 73 | 11 | int:GAPDH |
| Interaction | MACROH2A1 interactions | 4.00e-05 | 458 | 73 | 9 | int:MACROH2A1 | |
| Interaction | PABPC1 interactions | TET2 ACE2 EPRS1 CTTNBP2 ATXN2 TLN1 CPEB4 API5 HNRNPAB GOLGA4 HNRNPU | 4.06e-05 | 699 | 73 | 11 | int:PABPC1 |
| Interaction | HECTD1 interactions | BPTF EPRS1 URB1 CDK12 DCTN2 DIDO1 USP15 ITGB2 UTRN HSPA4 HNRNPAB HNRNPU FBXW7 | 4.68e-05 | 984 | 73 | 13 | int:HECTD1 |
| Interaction | RHPN1 interactions | 4.70e-05 | 55 | 73 | 4 | int:RHPN1 | |
| Interaction | HUNK interactions | 4.73e-05 | 109 | 73 | 5 | int:HUNK | |
| Interaction | ASH2L interactions | 4.88e-05 | 265 | 73 | 7 | int:ASH2L | |
| Interaction | PRMT5 interactions | 4.97e-05 | 471 | 73 | 9 | int:PRMT5 | |
| Interaction | SYNCRIP interactions | EPRS1 RPUSD4 ATXN2 UBE3A TLN1 CPEB4 THUMPD1 TLN2 HNRNPAB HNRNPU FBXW7 | 5.37e-05 | 721 | 73 | 11 | int:SYNCRIP |
| Interaction | SMC4 interactions | 7.06e-05 | 281 | 73 | 7 | int:SMC4 | |
| Interaction | RPL28 interactions | 7.17e-05 | 494 | 73 | 9 | int:RPL28 | |
| Interaction | PPIA interactions | ACE2 BPTF ACTR8 UBE3A CDK12 UBA2 DIDO1 TLN2 USP15 HNRNPAB GOLGA4 SPDL1 | 7.67e-05 | 888 | 73 | 12 | int:PPIA |
| Interaction | RPL36 interactions | 8.35e-05 | 504 | 73 | 9 | int:RPL36 | |
| Interaction | ALB interactions | 8.36e-05 | 391 | 73 | 8 | int:ALB | |
| Interaction | RBBP7 interactions | 8.74e-05 | 507 | 73 | 9 | int:RBBP7 | |
| Interaction | NPM1 interactions | ACE2 EPRS1 URB1 DIDO1 AKAP11 API5 ATAT1 USP15 UTRN TFAP2A HSPA4 HNRNPU SPDL1 FBXW7 | 8.93e-05 | 1201 | 73 | 14 | int:NPM1 |
| Interaction | NCAPG interactions | 9.17e-05 | 202 | 73 | 6 | int:NCAPG | |
| Interaction | BAZ1B interactions | 9.68e-05 | 204 | 73 | 6 | int:BAZ1B | |
| Interaction | ACTN4 interactions | 9.79e-05 | 400 | 73 | 8 | int:ACTN4 | |
| Interaction | FLII interactions | 1.02e-04 | 298 | 73 | 7 | int:FLII | |
| Interaction | FOCAD interactions | 1.02e-04 | 67 | 73 | 4 | int:FOCAD | |
| Interaction | H2BC3 interactions | 1.08e-04 | 406 | 73 | 8 | int:H2BC3 | |
| Interaction | TAF15 interactions | 1.12e-04 | 408 | 73 | 8 | int:TAF15 | |
| Interaction | RPLP0 interactions | 1.28e-04 | 660 | 73 | 10 | int:RPLP0 | |
| Interaction | CAD interactions | 1.33e-04 | 418 | 73 | 8 | int:CAD | |
| Interaction | YWHAE interactions | TET2 ACE2 UBE3A CDK12 KIAA0232 SMARCC2 AKAP11 API5 PEAK1 ATAT1 HSPA4 HNRNPAB HNRNPU FBXW7 | 1.43e-04 | 1256 | 73 | 14 | int:YWHAE |
| Interaction | WDR5 interactions | TET2 EPRS1 ZZZ3 UBE3A TLN1 SMARCC2 API5 ITGB2 UTRN HSPA4 HNRNPAB HNRNPU FBXW7 | 1.46e-04 | 1101 | 73 | 13 | int:WDR5 |
| Interaction | RTRAF interactions | 1.54e-04 | 222 | 73 | 6 | int:RTRAF | |
| Interaction | HMGN2 interactions | 1.54e-04 | 222 | 73 | 6 | int:HMGN2 | |
| Interaction | SERBP1 interactions | ACE2 EPRS1 ATXN2 UBE3A CDK12 DCTN2 TLN1 UBA2 DIDO1 USP15 HSPA4 USP47 HNRNPU ZNF292 FBXW7 | 1.59e-04 | 1432 | 73 | 15 | int:SERBP1 |
| Interaction | GLDC interactions | 1.61e-04 | 321 | 73 | 7 | int:GLDC | |
| Interaction | PPP1R12A interactions | 1.64e-04 | 322 | 73 | 7 | int:PPP1R12A | |
| Interaction | SMC2 interactions | 1.68e-04 | 323 | 73 | 7 | int:SMC2 | |
| Interaction | BCLAF1 interactions | 1.81e-04 | 327 | 73 | 7 | int:BCLAF1 | |
| Interaction | VHL interactions | 1.87e-04 | 561 | 73 | 9 | int:VHL | |
| Interaction | H2BC5 interactions | 1.95e-04 | 331 | 73 | 7 | int:H2BC5 | |
| Interaction | AURKA interactions | EPRS1 TCEAL2 UBA2 OTUD3 PEAK1 TFAP2A HSPA4 USP47 HNRNPU FBXW7 | 1.97e-04 | 696 | 73 | 10 | int:AURKA |
| Interaction | NCAPD2 interactions | 2.04e-04 | 234 | 73 | 6 | int:NCAPD2 | |
| Interaction | RBBP4 interactions | 2.19e-04 | 573 | 73 | 9 | int:RBBP4 | |
| Interaction | DEPTOR interactions | 2.24e-04 | 82 | 73 | 4 | int:DEPTOR | |
| Interaction | SOX7 interactions | 2.24e-04 | 82 | 73 | 4 | int:SOX7 | |
| Interaction | RUVBL1 interactions | 2.25e-04 | 575 | 73 | 9 | int:RUVBL1 | |
| Interaction | YY1 interactions | 2.33e-04 | 454 | 73 | 8 | int:YY1 | |
| Interaction | PGR interactions | 2.46e-04 | 84 | 73 | 4 | int:PGR | |
| Interaction | SAE1 interactions | 2.49e-04 | 155 | 73 | 5 | int:SAE1 | |
| Interaction | BCR interactions | 2.56e-04 | 244 | 73 | 6 | int:BCR | |
| Interaction | HDAC2 interactions | TET2 BPTF SMARCC2 SSX2 USP15 HSPA4 EMSY GOLGA4 HNRNPU HR FBXW7 | 2.67e-04 | 865 | 73 | 11 | int:HDAC2 |
| Interaction | NXF1 interactions | EPRS1 LUZP4 RPUSD4 URB1 ATXN2 DCTN2 TLN1 BTBD18 SMARCC2 USP15 HSPA4 HNRNPAB EMSY FBXW7 | 2.92e-04 | 1345 | 73 | 14 | int:NXF1 |
| Interaction | NLRP7 interactions | 2.96e-04 | 161 | 73 | 5 | int:NLRP7 | |
| Interaction | EIF4A1 interactions | 2.98e-04 | 355 | 73 | 7 | int:EIF4A1 | |
| Interaction | GOLGA6L2 interactions | 2.99e-04 | 36 | 73 | 3 | int:GOLGA6L2 | |
| Interaction | SEM1 interactions | 3.05e-04 | 162 | 73 | 5 | int:SEM1 | |
| Interaction | RPL21 interactions | 3.08e-04 | 357 | 73 | 7 | int:RPL21 | |
| Interaction | UBA2 interactions | 3.11e-04 | 253 | 73 | 6 | int:UBA2 | |
| Interaction | H2BC4 interactions | 3.52e-04 | 259 | 73 | 6 | int:H2BC4 | |
| Interaction | PSMC5 interactions | 3.58e-04 | 484 | 73 | 8 | int:PSMC5 | |
| Interaction | MORF4L2 interactions | 3.61e-04 | 168 | 73 | 5 | int:MORF4L2 | |
| Interaction | H3C1 interactions | ACE2 BPTF EPRS1 SMARCC2 DIDO1 HMGN2 API5 HNRNPAB HNRNPU SPDL1 ZNF292 | 3.77e-04 | 901 | 73 | 11 | int:H3C1 |
| Interaction | RCOR1 interactions | 4.10e-04 | 494 | 73 | 8 | int:RCOR1 | |
| Interaction | RPL4 interactions | 4.14e-04 | 764 | 73 | 10 | int:RPL4 | |
| Interaction | SPAG9 interactions | 4.22e-04 | 268 | 73 | 6 | int:SPAG9 | |
| Interaction | TUBA1B interactions | 4.32e-04 | 498 | 73 | 8 | int:TUBA1B | |
| Interaction | CKB interactions | 4.39e-04 | 270 | 73 | 6 | int:CKB | |
| Interaction | HNRNPC interactions | 4.60e-04 | 634 | 73 | 9 | int:HNRNPC | |
| Interaction | FGF14 interactions | 4.73e-04 | 42 | 73 | 3 | int:FGF14 | |
| Interaction | CPNE5 interactions | 4.73e-04 | 42 | 73 | 3 | int:CPNE5 | |
| Interaction | RAD21 interactions | 4.78e-04 | 384 | 73 | 7 | int:RAD21 | |
| Interaction | YWHAG interactions | TET2 UBE3A CDK12 KIAA0232 USP12 AKAP11 API5 PEAK1 ATAT1 UTRN HSPA4 HNRNPAB FBXW7 | 4.92e-04 | 1248 | 73 | 13 | int:YWHAG |
| Interaction | ZFP36 interactions | 5.07e-04 | 181 | 73 | 5 | int:ZFP36 | |
| Interaction | MED29 interactions | 5.15e-04 | 102 | 73 | 4 | int:MED29 | |
| Interaction | EPRS1 interactions | 5.26e-04 | 513 | 73 | 8 | int:EPRS1 | |
| Interaction | RPS9 interactions | 5.39e-04 | 515 | 73 | 8 | int:RPS9 | |
| Cytoband | Xq22.1-q22.3 | 3.73e-05 | 6 | 73 | 2 | Xq22.1-q22.3 | |
| GeneFamily | GATA zinc finger domain containing|Myb/SANT domain containing | 3.09e-04 | 53 | 45 | 3 | 532 | |
| GeneFamily | Ubiquitin specific peptidases | 3.64e-04 | 56 | 45 | 3 | 366 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 9.04e-04 | 18 | 45 | 2 | 91 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | PRUNE2 EPRS1 USF3 ZZZ3 ATXN2 CPEB4 USP12 BEX4 AKAP11 NCOA4 UTRN GOLGA4 ZNF292 | 1.60e-06 | 946 | 72 | 13 | M39169 |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | BPTF EPRS1 CTTNBP2 ZZZ3 UBE3A TCEAL2 USP12 AKAP11 GOLGA4 USP47 SPDL1 | 1.68e-06 | 656 | 72 | 11 | M18979 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | BPTF ZBTB44 UBE3A PPP1R15B TLN1 DEF6 UBA2 CRYBG1 AKAP11 USP15 ITGB2 UTRN USP47 HNRNPU ZNF292 | 1.06e-05 | 1492 | 72 | 15 | M40023 |
| Coexpression | GABRIELY_MIR21_TARGETS | 1.47e-05 | 289 | 72 | 7 | M2196 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.92e-08 | 200 | 73 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.50e-07 | 192 | 73 | 6 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 7.73e-07 | 193 | 73 | 6 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Control / Disease condition and Cell class | 8.21e-07 | 195 | 73 | 6 | 0fea64ee3eedf3929abb0dd9c5f5fc72f181eed9 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 8.97e-07 | 198 | 73 | 6 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.24e-07 | 199 | 73 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 9.51e-07 | 200 | 73 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | RV-16._Neuronal|World / Chamber and Cluster_Paper | 4.67e-06 | 149 | 73 | 5 | 3a2f8c4173dcf9e3f8d3b8ffddbc597098adf7a9 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 6.80e-06 | 161 | 73 | 5 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.52e-05 | 190 | 73 | 5 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 1.63e-05 | 193 | 73 | 5 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | wk_08-11-Hematologic-Meg-ery-Definitive_erythroblast|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.63e-05 | 193 | 73 | 5 | be75abfdf5301cf33df8ee9ed92504d44fdf19a6 | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.80e-05 | 197 | 73 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC_fresh-frozen|World / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.85e-05 | 198 | 73 | 5 | dcc223a0396b8b673e4ed8c6733ec6cd74e9a03a | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.85e-05 | 198 | 73 | 5 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.85e-05 | 198 | 73 | 5 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.89e-05 | 199 | 73 | 5 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.89e-05 | 199 | 73 | 5 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | RV-16._Neuronal|RV / Chamber and Cluster_Paper | 1.17e-04 | 153 | 73 | 4 | bed8bbf5c5cbfbf46a816066da472c3fdddecb5d | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Lymphocytic-Epcam____proximal_tube_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-04 | 158 | 73 | 4 | 1d78578dc1f8ba43dacdccae1082c0b9d749f64d | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.39e-04 | 160 | 73 | 4 | 29c9b4770d0e73d59cffc7937b179484c76b6dcc | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.49e-04 | 163 | 73 | 4 | a6e272e043859858084b8d4d96fa4ff9e6eca454 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-epithelial_progenitor_cell-Stem_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-04 | 168 | 73 | 4 | b08458164d270d625b8ee390122d1c2ce8c653db | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 1.79e-04 | 171 | 73 | 4 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.83e-04 | 172 | 73 | 4 | fe3d0d8cb5f613ac2cfff450599698f1533a354f | |
| ToppCell | Club-club-15|World / Class top | 1.95e-04 | 175 | 73 | 4 | ca9d012f520f697c7450ec6958a015e20538a6a8 | |
| ToppCell | wk_20-22-Epithelial-PNS-Late_Schwann|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.00e-04 | 176 | 73 | 4 | 81924471d8a8c5bd8eedf294c007e25b6cd3e417 | |
| ToppCell | Caecum-Macrophage-LYVE1_Macrophage|Macrophage / Region, Cell class and subclass | 2.07e-04 | 70 | 73 | 3 | 05f8fc648641b9db50c2ae20d6246b52869957cf | |
| ToppCell | droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-04 | 179 | 73 | 4 | a09647750eba9d93c5efc1db3b555fefb5eec7b5 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.17e-04 | 180 | 73 | 4 | 67c5068b660cd5e727a665cefe3bd5f8ae887221 | |
| ToppCell | facs-Lung-Endomucin_-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-04 | 181 | 73 | 4 | 4ea02344e1996f264dd5e14f3b19c8782ce41699 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Definitive_erythroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.27e-04 | 182 | 73 | 4 | 93841f730ca1a735eaaf5f2ccbe5c45ab0e029d1 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.27e-04 | 182 | 73 | 4 | f96095b81188b52db8fcfca4837129cfcd9bd7b7 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.27e-04 | 182 | 73 | 4 | ebc812ed3f25839ea25f76b952c463d79a8325b1 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.27e-04 | 182 | 73 | 4 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.27e-04 | 182 | 73 | 4 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.27e-04 | 182 | 73 | 4 | 47ff6b4002a4167412c79210651316d1342503f9 | |
| ToppCell | Adult-Epithelial-basal_cell|Adult / Lineage, Cell type, age group and donor | 2.32e-04 | 183 | 73 | 4 | 00a6b19ca49e3b8e0d1cd387a3515b0ff4b81c81 | |
| ToppCell | droplet-Heart-4Chambers-21m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 183 | 73 | 4 | 4de2082dca2569d3aac3c9b466f27971c82d302b | |
| ToppCell | droplet-Heart-4Chambers-21m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 183 | 73 | 4 | a046b569bc10083d471b420eb2c6fee93437602d | |
| ToppCell | pdx|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.46e-04 | 186 | 73 | 4 | de8e538c8767d41b8a52f5e58ba1affd4e7244c4 | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.46e-04 | 186 | 73 | 4 | c116cc9f41971622264434ebe29d18e719b0ae19 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-04 | 186 | 73 | 4 | 4ae3c0fe8640a8d029875cf3f0f5ffbba38e85f8 | |
| ToppCell | pdx-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.46e-04 | 186 | 73 | 4 | 0b88a87158a9ca8de3bf40a4ff1687150707a5f0 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.46e-04 | 186 | 73 | 4 | 5302399825f213d105ac70b91366a4513b732838 | |
| ToppCell | RV-07._Pericyte|World / Chamber and Cluster_Paper | 2.51e-04 | 187 | 73 | 4 | dc274d6bbda619a2c914d84e2b4069cfef1739d1 | |
| ToppCell | ILEUM-inflamed-(5)_Plasma-(5)_IgA_plasma_cells|(5)_Plasma / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.62e-04 | 189 | 73 | 4 | a0634d72bfdd5f93877724ed6480b50a3a046f71 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_naive-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.62e-04 | 189 | 73 | 4 | 55aba1ebc012006a5db3ff9c92589cb3d9f7c68a | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor1_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 2.67e-04 | 190 | 73 | 4 | 773c55b9e28c2f77a5eb5f0adb0fa9862fb9611d | |
| ToppCell | CD8+_Memory_T_cell-CV-7|CD8+_Memory_T_cell / cell class, Virus stimulation and cluster | 2.72e-04 | 191 | 73 | 4 | 9454f642c3621370fa23640b631301346b300950 | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.72e-04 | 191 | 73 | 4 | 3307dbccadb09c62b0e1c0235ec89bb294d748c3 | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.72e-04 | 191 | 73 | 4 | 6e6b2cb390cc5cd0356924a2c36fbe5b5bd5966c | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.72e-04 | 191 | 73 | 4 | 482db995930346be69072ace2fd78fd453e97fb5 | |
| ToppCell | E15.5-Epithelial-epithelial_progenitor_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.78e-04 | 192 | 73 | 4 | cb6f42dcffe650f7958543531d8f5412b2f2eb12 | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic-erythrocyte|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.83e-04 | 193 | 73 | 4 | 305e15ee467826ee08b2617c69f250ad39c11b19 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.83e-04 | 193 | 73 | 4 | 3a9fe4e709c09ec787c71bdd6b58a71c419896de | |
| ToppCell | critical-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.83e-04 | 193 | 73 | 4 | 6be11fef87af04ee7a3cc223882ccd4077caded9 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 2.83e-04 | 193 | 73 | 4 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | 10x_3'_v3-bone_marrow_(10x_3'_v3)-hematologic-erythrocytic|bone_marrow_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.83e-04 | 193 | 73 | 4 | dd376664906caccc9c2065f8e7a364509e18a5cc | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-04 | 194 | 73 | 4 | 415801a3dfacf05f2b603fb424df3d045190a812 | |
| ToppCell | Mild/Remission-B_activate-7|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.89e-04 | 194 | 73 | 4 | 01c97543972159a9468272da06e7e611e2c21fae | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-04 | 194 | 73 | 4 | 256cb33ec90328f2704921fb0fe0fd9812e138b0 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-04 | 194 | 73 | 4 | 7942bc83c1bdca687795b91aa232824d603f9b09 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-04 | 195 | 73 | 4 | 2416efe0b10ef28d0107808d1347bc34f87f92b7 | |
| ToppCell | (00)_Basal-(0)_Reference|(00)_Basal / shred by cell type by condition | 3.01e-04 | 196 | 73 | 4 | ba03530a20d7b29902721fd50df8d860557ddefa | |
| ToppCell | 367C-Epithelial_cells-Epithelial-H_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.01e-04 | 196 | 73 | 4 | e8db58e82300981f981402618a1befb91f6690fd | |
| ToppCell | 367C-Epithelial_cells-Epithelial-H_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.01e-04 | 196 | 73 | 4 | 2cf42b702ea15adfa6bbd86a3c9613271863f86c | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.06e-04 | 197 | 73 | 4 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | (04)_Interm._basal>secr.-(0)_Reference|(04)_Interm._basal>secr. / shred by cell type by condition | 3.06e-04 | 197 | 73 | 4 | 452462b372c66e7487de7b9140717954e1d05263 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 3.06e-04 | 197 | 73 | 4 | eb7610c9496a95a5fd866e16abcbc39b83abe617 | |
| ToppCell | Sigmoid-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass | 3.12e-04 | 198 | 73 | 4 | 305d7ae9b070ac7211638a5282374c02bf13af40 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_2|COVID-19_Convalescent / Disease condition and Cell class | 3.12e-04 | 198 | 73 | 4 | f65fd9b773aeafa55e38309479954a8e41371f52 | |
| ToppCell | 3'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-04 | 198 | 73 | 4 | 7ad7726fc405806b1d7824f58548073ea5e0c70b | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-04 | 198 | 73 | 4 | 1fbec311f2c987ca90a023a5989128c05aa12d5c | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.12e-04 | 198 | 73 | 4 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-04 | 198 | 73 | 4 | ceede961ad9af6a3159db7efaa5087bf38aafc2d | |
| ToppCell | Severe-B_intermediate-6|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.12e-04 | 198 | 73 | 4 | 8402421dc060926e968efe39a4e907f1e8ae5b1f | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.12e-04 | 198 | 73 | 4 | 4f26a60e99f42343e5af7221723e108a1a1b7827 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-04 | 199 | 73 | 4 | 8d50e1ee58710d896c0204937331d9f4dcd38de0 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 3.18e-04 | 199 | 73 | 4 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 3.18e-04 | 199 | 73 | 4 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 3.18e-04 | 199 | 73 | 4 | b2d7dea11207cca63d688f8051143850b29dbdf0 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 3.18e-04 | 199 | 73 | 4 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.18e-04 | 199 | 73 | 4 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_2|Classical_Monocyte / Disease condition and Cell class | 3.18e-04 | 199 | 73 | 4 | 3feee9f53860b4b2e93ff2360beb2b2b74f51d24 | |
| ToppCell | Severe-B_intermediate-6|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.18e-04 | 199 | 73 | 4 | bf6ebb63ab361d9d1946225894d7be433e9befab | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 3.18e-04 | 199 | 73 | 4 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.18e-04 | 199 | 73 | 4 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.24e-04 | 200 | 73 | 4 | ed093626a9cac7531a2bf02f6e345c5e84b8c060 | |
| ToppCell | Skin-Keratinocytes|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 3.24e-04 | 200 | 73 | 4 | 59d72395199bc30df0e811fbc99149694e208860 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW09-Neuronal-Cortical_neuron|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 3.24e-04 | 200 | 73 | 4 | 44bc4d6616fc8d0ad8498e56125939034e8cff01 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Cortical_neuron|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 3.24e-04 | 200 | 73 | 4 | 19055194a5e0ea122f1b8fc62df44813f6843c95 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-3m|organoid_Tanaka_cellReport / Sample Type, Dataset, Time_group, and Cell type. | 3.24e-04 | 200 | 73 | 4 | e4f0bb57be1112869c7068d0a789c2b802a442dd | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 3.24e-04 | 200 | 73 | 4 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | COVID-19-COVID-19_Mild|COVID-19 / Disease, condition lineage and cell class | 3.24e-04 | 200 | 73 | 4 | 62c25042086f1afd1102e0720e933c2e476468fd | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 1.90e-06 | 49 | 46 | 5 | GAVISH_3CA_MALIGNANT_METAPROGRAM_41_UNASSIGNED | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.40e-05 | 49 | 46 | 4 | GAVISH_3CA_METAPROGRAM_CD8_T_CELLS_CHROMATIN | |
| Computational | Neighborhood of ANP32B | 5.15e-04 | 37 | 46 | 3 | GNF2_ANP32B | |
| Computational | Neighborhood of APEX1 | 6.23e-04 | 92 | 46 | 4 | GNF2_APEX1 | |
| Disease | eosinophil count | TET2 BPTF ATXN2 KIAA0232 CPEB4 HMGN2 PEAK1 USP15 HSPA4 EMSY ZNF292 FBXW7 | 2.09e-04 | 1488 | 71 | 12 | EFO_0004842 |
| Disease | low affinity immunoglobulin gamma Fc region receptor III-B measurement | 5.10e-04 | 14 | 71 | 2 | EFO_0008212 | |
| Disease | temporal horn of lateral ventricle volume measurement | 7.07e-04 | 72 | 71 | 3 | EFO_0010333 | |
| Disease | Epilepsy, Cryptogenic | 1.03e-03 | 82 | 71 | 3 | C0086237 | |
| Disease | Awakening Epilepsy | 1.03e-03 | 82 | 71 | 3 | C0751111 | |
| Disease | Aura | 1.03e-03 | 82 | 71 | 3 | C0236018 | |
| Disease | rheumatoid arthritis, ulcerative colitis | 1.16e-03 | 21 | 71 | 2 | EFO_0000685, EFO_0000729 | |
| Disease | serum gamma-glutamyl transferase measurement | 1.56e-03 | 914 | 71 | 8 | EFO_0004532 | |
| Disease | neutrophil count | PRUNE2 TET2 RPUSD4 ATXN2 DEF6 SYPL2 TLN2 AKAP11 USP47 ZNF292 | 1.68e-03 | 1382 | 71 | 10 | EFO_0004833 |
| Disease | platelet component distribution width | 2.25e-03 | 755 | 71 | 7 | EFO_0007984 | |
| Disease | Epilepsy | 2.34e-03 | 109 | 71 | 3 | C0014544 | |
| Disease | lactate measurement | 3.99e-03 | 39 | 71 | 2 | EFO_0007745 | |
| Disease | Intellectual Disability | 4.48e-03 | 447 | 71 | 5 | C3714756 | |
| Disease | inflammatory bowel disease | 4.56e-03 | 449 | 71 | 5 | EFO_0003767 | |
| Disease | beta-nerve growth factor measurement | 4.62e-03 | 42 | 71 | 2 | EFO_0008035 | |
| Disease | colorectal cancer, endometrial neoplasm | 4.62e-03 | 42 | 71 | 2 | EFO_0004230, MONDO_0005575 | |
| Disease | primary immunodeficiency disease (is_implicated_in) | 4.62e-03 | 42 | 71 | 2 | DOID:612 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SLEENNSDKNSGPQG | 1226 | Q9NYV4 | |
| GQEEQPGSENANLRN | 406 | A6NCI8 | |
| NAQQENEGGEQAPTQ | 16 | Q9NWD9 | |
| GLNKPESNEQRQNGL | 96 | Q9H981 | |
| QNAESQGKAPEEQGL | 66 | Q8N4X5 | |
| NKDNLFGGVVNPNEV | 196 | P05549 | |
| EHNPGNQNDFKPTND | 841 | Q9UKA4 | |
| ENGENAGNEEPKLQF | 326 | Q9BZZ5 | |
| DQDAQNPLSAGLQGA | 241 | Q13561 | |
| NGLPINKNENVNGES | 1691 | Q12830 | |
| QSEGNQHQSEGNPDK | 131 | Q9P127 | |
| NEEGGNDNQDNENPG | 426 | Q5TC84 | |
| EQKNAEQNGPVDGQG | 796 | P34932 | |
| EALQKEGGNQQQAAS | 1321 | Q13439 | |
| LQDQRQNSPAGNKEN | 751 | Q99700 | |
| GNNPAENGDAKTDQA | 66 | P05204 | |
| GGDNNPLDNLALEQK | 951 | Q8IVV2 | |
| QEQKQQEGYDGGPNL | 361 | Q6P5Q4 | |
| SGQHDEQKGPQDGQA | 461 | O43593 | |
| EQKGPQDGQASLQDP | 466 | O43593 | |
| FEQNDQPKSGENGLN | 996 | Q92628 | |
| LSQKPLNNNNEDDEG | 111 | Q9H792 | |
| QQPQQQRGAAKEAAG | 171 | Q00839 | |
| GGSKKESEEPNQGNN | 126 | Q9H7Z3 | |
| QGLNEGRTENNKAQA | 311 | Q5T2D3 | |
| QGNQPKGVEIENLGN | 351 | Q13772 | |
| ETQEDHNGGQKQLSP | 86 | P05107 | |
| KEEGPQENNRQNADN | 186 | B2RXH4 | |
| RFQGNANDPDQNGNT | 451 | Q8WZ74 | |
| DFQKPNGSQAGNANE | 2601 | Q9Y6R7 | |
| DDFQKPNGSQAGNAN | 3801 | Q9Y6R7 | |
| PGGQNDSQQGQLEEN | 66 | Q969H0 | |
| KQEPENDQGVVSQAG | 216 | Q9BTC0 | |
| ISKGENNPGFQNTDD | 786 | Q9BYF1 | |
| NEQQKSLNGGDEAPA | 601 | Q9H4E7 | |
| LPDQQAEDQQAKGEQ | 561 | Q96JA4 | |
| SPKGQFQNVQAEGQQ | 616 | Q96JA4 | |
| SPNTGNQDSKQGEQE | 346 | Q5SQI0 | |
| EENQGDNSSENGNGK | 116 | Q17RY0 | |
| AGNSSIQEGKEEPQN | 701 | Q7Z589 | |
| NQALGPQPNQDDKAD | 366 | Q9Y4K1 | |
| PNEDQNENNEAKCLG | 361 | Q96CM3 | |
| EASQAQEDPGQGDQQ | 171 | Q8IYJ3 | |
| QDQDQDQDQGQGPSQ | 246 | Q5VXT5 | |
| KQQAAQGDDAGLQRQ | 1041 | P46939 | |
| QNDGQRKDPSKNQGG | 981 | P07814 | |
| QNGAEGDQINASKNE | 51 | Q99729 | |
| GQPELGSNDIQDKNE | 721 | Q8WUY3 | |
| GNDFDNDPNRGNQVQ | 81 | Q99909 | |
| DQALQQALDPNSKGN | 241 | Q96EA4 | |
| ASDQQNEPQLGLKDQ | 296 | Q9UBT2 | |
| EQTKDPQGEDGQNNN | 381 | Q8WU08 | |
| QANKGQDLPTPDQDN | 306 | Q5SWA1 | |
| DENSTGNKGEQTKNP | 396 | Q8TAQ2 | |
| GGQQDDDNTQNQEKE | 1396 | O60287 | |
| NQNGGNDDKTKNAER | 391 | Q9NQ89 | |
| EGGVNQEDGPDQQQN | 456 | O94967 | |
| PQPVSKQNGAGEDNQ | 1231 | Q9HCE3 | |
| KQNGAGEDNQQENKP | 1236 | Q9HCE3 | |
| DSSQGDNNLQKLGPD | 216 | Q05086 | |
| GNDLDNDPNRGNQVE | 81 | Q16385 | |
| SQNAKNGNLPEFGDA | 1411 | Q9Y490 | |
| GNDFDNDPNRGNQVE | 81 | O60225 | |
| RDQGNQEQDPNISNG | 186 | Q14515 | |
| QPEKGLDAGQENNSN | 136 | Q8NCP5 | |
| QEKQNGRLPNGNIDN | 146 | O75317 | |
| GRLPNGNIDNENNNS | 151 | O75317 | |
| INPNITSQDKNEQGG | 1211 | O60281 | |
| KSLSLQQQQDGDNGD | 881 | Q96K76 | |
| DQNINGNGPNGIHEE | 636 | Q9Y4E8 | |
| NENEGMPSNQGKIDN | 6 | Q9H3H9 | |
| NDQNSSENKNGQENP | 276 | Q68DE3 | |
| NCPNVPNNDQKDTDG | 541 | P49746 | |
| DPGPGDQEKQQQASE | 121 | P52736 | |
| AAKGAAANPENEDQQ | 876 | Q9Y4G6 | |
| QEQEDNKRGPCSNGE | 131 | Q5PR19 | |
| DANGQEKQPLALVQG | 1821 | Q6N021 | |
| DDCQPDGNTKQNSIG | 216 | Q8IYH5 | |
| DQNNTAEGKNNQQVP | 296 | Q9NXG2 | |
| PVKEENVAGRGNQQN | 811 | Q9H0D2 |